Health Condition 1: N209- Urinary calculus, unspecified
Conditions
Interventions
None listed
Sponsors
National Institute of Ayurveda, Deemed To Be University,jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients Of Either Sex Male Or Female. 2. Patients Of Age Group From 18 to 60 Years. 3. Patient having renal and ureteric stones with Size Upto Less Than Or Equal To 10mm Will Be Include In This Trial .
Exclusion criteria
Exclusion criteria: 1.Age Below 18 Years And More Than 60 Years. 2.Patient With Obstructive Uropathy. 3.Patient With Chronic Kidney Diseases, Nephrotic Syndrome. 4.Patient With Hydronephrosis .(Grade3 And Grade4) Grade 3 (Moderate)- Moderate Dilation Of The Renal Pelvis And Calyces. Blunting Of Fornices And Flattening Of Papillae Mild Cortical Thinning May Be Seen. Grade 4 (severe)- Gross Dilation Of The Renal Pelvis And Caleyes, Which Appear Ballooned . Loss Of Border Between The Renal Pelvis And Calcyes. Renal Atrophy Seen As Cortical Thinning 5.Patient With Evidence Of Malignancy. 6.Patient With Poorly Controlled Diabetes Mellitus (HBA1C More Than 8%). 7.Pregnant Or Lactating Women. 8.Symptomatic Patients With Clinical Evidence Of Heart Failure. 9.Patient With Urolithiasis (Mutrashmari) With Complication, Such As AcutE Renal Failure, Sepsis, Anuria, Urinary Tract Infection With Renal Obsturction 10.Urinary Stones Of More Than 10mm Size. 11.Uncontrolled Hypertension (Systolic Blood Pressure More Than 160mmHg Or Diastolic Blood Pressure More Than 100 mmHg). 12.Presence Of Any Other Serious Medical Condition That May Interfere With Study Participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Primary Outcome Of The Study Will Be Change In Size Of Renal Or Ureteric Calculus As Assessed By Ultrasonography (KUB),From Base Line To End Of The Treatment Period.Timepoint: Base Line To The End Of The Treatment Period | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcome Will Include 1.Change In Clinical Symptoms Of Urolithiasis (Pain In Renal Angle And Loin Region,Radiating Toward The Groin, Burning Micturition, Dysuria, Hematuria, Nausea/Vomiting) 2. Change In Urine Microscopic Parameters (Pus Cells, RBCs, Urinary Crystals, Microbial Load). Safety Assessed By Monitoring Adverse Events. Timepoint: Baseline, Day 15, Day 30, and Day 45. | — |
Countries
India
Contacts
Public ContactPROF HARI MOHAN LAL MEENA
National Institute of Ayurveda, Deemed to be university, Jaipur
Outcome results
None listed